Natural history of NF1 c.2970_2972del p.(Met992del): confirmation of a low risk of complications in a longitudinal study
0303 health sciences
03 medical and health sciences
Neurofibroma
Neurofibromatosis 1
Cafe-au-Lait Spots
Humans
[SDV.GEN] Life Sciences [q-bio]/Genetics
Longitudinal Studies
Article
Genetic Association Studies
3. Good health
DOI:
10.1038/s41431-021-01015-4
Publication Date:
2021-12-13T02:02:42Z
AUTHORS (29)
ABSTRACT
Abstract Individuals with the three base pair deletion NM_000267.3(NF1):c.2970_2972del p.(Met992del) have been recognised to present a milder neurofibromatosis type 1 (NF1) phenotype characterised by café-au-lait macules (CALs) and intertriginous freckling, as well lack of cutaneous, subcutaneous plexiform neurofibromas other NF1-associated complications. Examining large cohorts patients over time this specific genotype is important confirm presentation associated risks variant across lifespan. Forty-one individuals in-frame NF1 p.Met992del were identified from 31 families. Clinicians completed standardised clinical questionnaire for each patient resulting data collated compared published cohorts. Thirteen previously reported, updated information has obtained these individuals. Both CALs freckling in majority (26/41, 63%) only confirmed features 11 (27%). 34/41 (83%) cohort met NIH diagnostic criteria. There was notable absence all tumour types (neurofibroma glioma). Neurofibroma observed one individual—a lesion (confirmed histologically). Nineteen described having learning disability (46%). This study confirms that display mild tumoural those ‘classical’, clinically diagnosed NF1, appears be case longitudinally through at presentation. Learning difficulties, however, appear affect significant proportion subjects phenotype. Knowledge genotype–phenotype association fundamental accurate prognostication families caregivers.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (31)
CITATIONS (7)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....